160 related articles for article (PubMed ID: 37827334)
1. Deletion of hepatic small heterodimer partner ameliorates development of nonalcoholic steatohepatitis in mice.
Lee YK; Park JE; Lee M; Mifflin R; Xu Y; Novak R; Zhang Y; Hardwick JP
J Lipid Res; 2023 Nov; 64(11):100454. PubMed ID: 37827334
[TBL] [Abstract][Full Text] [Related]
2. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
3. SHP-1 ameliorates nonalcoholic steatohepatitis by inhibiting proinflammatory cytokine production.
Lin L; Jian J; Song CY; Chen F; Ding K; Xie WF; Hu PF
FEBS Lett; 2020 Sep; 594(18):2965-2974. PubMed ID: 32619269
[TBL] [Abstract][Full Text] [Related]
4. Microbial products linked to steatohepatitis are reduced by deletion of nuclear hormone receptor SHP in mice.
Mifflin R; Park JE; Lee M; Jena PK; Wan YY; Barton HA; Aghayev M; Kasumov T; Lin L; Wang X; Novak R; Li F; Huang H; Shriver LP; Lee YK
J Lipid Res; 2023 Dec; 64(12):100469. PubMed ID: 37922990
[TBL] [Abstract][Full Text] [Related]
5. 4,4-Diallyl curcumin bis(2,2-hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine-choline-deficient diet and Western diet mouse models.
Yang LC; Wang CC; Lee DY; Lin WC; Kuo SC; Juang SH; Hsieh MT
Chem Biol Drug Des; 2024 May; 103(5):e14532. PubMed ID: 38725089
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
[TBL] [Abstract][Full Text] [Related]
7. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
[TBL] [Abstract][Full Text] [Related]
8. Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis.
Alarcón-Vila C; Insausti-Urkia N; Torres S; Segalés-Rovira P; Conde de la Rosa L; Nuñez S; Fucho R; Fernández-Checa JC; García-Ruiz C
Redox Biol; 2023 Feb; 59():102596. PubMed ID: 36610223
[TBL] [Abstract][Full Text] [Related]
9. Ablation of IFNγ in myeloid cells suppresses liver inflammation and fibrogenesis in mice with hepatic small heterodimer partner (SHP) deletion.
Zhu L; Litts B; Wang Y; Rein JA; Atzrodt CL; Chinnarasu S; An J; Thorson AS; Xu Y; Stafford JM
Mol Metab; 2024 May; 83():101932. PubMed ID: 38589002
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CCR1 regulates macrophage activation through mTORC1 signaling in nonalcoholic steatohepatitis.
Li H; Pan T; Gao L; Ding R; Yu Y; Ma M; Wang Y; Jin S; Chen Y; Ding C; Xu L
Metabolism; 2024 Feb; 151():155758. PubMed ID: 38070823
[TBL] [Abstract][Full Text] [Related]
11. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis.
Son YJ; Jung DS; Shin JM; Kim M; Yoo G; Nho CW
BMC Complement Med Ther; 2021 Jan; 21(1):44. PubMed ID: 33494735
[TBL] [Abstract][Full Text] [Related]
12. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
Elife; 2023 Jan; 12():. PubMed ID: 36648330
[TBL] [Abstract][Full Text] [Related]
13. Epiberberine regulates lipid synthesis through SHP (NR0B2) to improve non-alcoholic steatohepatitis.
Zhou LM; Fan JH; Xu MM; Xiong MY; Wang QJ; Chai X; Li XD; Li XG; Ye XL
Biochim Biophys Acta Mol Basis Dis; 2023 Apr; 1869(4):166639. PubMed ID: 36638873
[TBL] [Abstract][Full Text] [Related]
14. Lower adiposity does not protect beta-2 syntrophin null mice from hepatic steatosis and inflammation in experimental non-alcoholic steatohepatitis.
Rein-Fischboeck L; Pohl R; Haberl EM; Mages W; Girke P; Liebisch G; Krautbauer S; Buechler C
Gene; 2023 Apr; 859():147209. PubMed ID: 36681100
[TBL] [Abstract][Full Text] [Related]
15. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
[TBL] [Abstract][Full Text] [Related]
16. Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis.
Liu W; Ye C; Cheng Q; Zhang X; Yao L; Li Q; Huang J; Liu Y; Zou Z; Wang H; Yan J; Zhu Y; Wang C; Ai D
Cell Mol Gastroenterol Hepatol; 2019; 7(1):211-231. PubMed ID: 30539788
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
18. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
[TBL] [Abstract][Full Text] [Related]
19. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]